Cytokine alterations in bipolar disorder: A meta-analysis of 30 studies

Biological Psychiatry

Volumn 74, Issue 1, 2013, Pages 15-25

  Modabbernia, Amirhossein ^a   Taslimi, Shervin ^a,b   Brietzke, Elisa ^c   Ashrafi, Mandana ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bipolar disorder; cytokine; euthymic; inflammation; mania; meta analysis

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6 RECEPTOR; MITOGENIC AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ARTICLE; BIOSIS; BIPOLAR DISORDER; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; STATISTICAL SIGNIFICANCE;

BIPOLAR DISORDER; CYTOKINES; HUMANS;

EID: 84879317123     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.01.007     Document Type: Article

References (123)

1. S. Potvin, E. Stip, A.A. Sepehry, A. Gendron, R. Bah, and E. Kouassi Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review Biol Psychiatry 63 2008 801 808
2. S.H. Abbasi, F. Hosseini, A. Modabbernia, M. Ashrafi, and S. Akhondzadeh Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study J Affect Disord 141 2012 308-114
3. K. Sepanjnia, A. Modabbernia, M. Ashrafi, M.J. Modabbernia, and S. Akhondzadeh Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: Randomized double-blind placebo-controlled trial Neuropsychopharmacology 37 2012 2093 2100
4. N. Muller, M.J. Schwarz, S. Dehning, A. Douhe, A. Cerovecki, and B. Goldstein-Muller The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine Mol Psychiatry 11 2006 680 684
5. Y. Dowlati, N. Herrmann, W. Swardfager, H. Liu, L. Sham, and E.K. Reim A meta-analysis of cytokines in major depression Biol Psychiatry 67 2010 446 457
6. B.I. Goldstein, D.E. Kemp, J.K. Soczynska, and R.S. McIntyre Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: A systematic review of the literature J Clin Psychiatry 70 2009 1078 1090
7. F.G. Nery, E.S. Monkul, J.P. Hatch, M. Fonseca, G.B. Zunta-Soares, and B.N. Frey Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: A double-blind, randomized, placebo-controlled study Hum Psychopharmacol 23 2008 87 94
8. E. Brietzke, M. Scheinberg, and B. Lafer Therapeutic potential of interleukin-6 antagonism in bipolar disorder Med Hypotheses 76 2011 21 23
9. Brietzke E, Stabellini R, Grassis-Oliveira R, Lafer B (2011): Cytokines in bipolar disorder: Recent findings, deleterious effects but promise for future therapeutics [published online ahead of print July 1]. CNS Spectr.
10. S.Y. Tsai, Y.Y. Yang, C.J. Kuo, C.C. Chen, and S.J. Leu Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania J Affect Disord 64 2001 185 193
11. A. Ortiz-Dominguez, M.E. Hernandez, C. Berlanga, D. Gutierrez-Mora, J. Moreno, and G. Heinze Immune variations in bipolar disorder: Phasic differences Bipolar Disord 9 2007 596 602
12. E. Brietzke, L. Stertz, B.S. Fernandes, M. Kauer-Sant'anna, M. Mascarenhas, and A. Escosteguy Vargas Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder J Affect Disord 116 2009 214 217
13. F. Kapczinski, V.V. Dias, M. Kauer-Sant'Anna, E. Brietzke, G.H. Vazquez, and E. Vieta The potential use of biomarkers as an adjunctive tool for staging bipolar disorder Prog Neuropsychopharmacol Biol Psychiatry 33 2009 1366 1371
14. M. Berk, P. Conus, F. Kapczinski, A.C. Andreazza, M. Yucel, and S.J. Wood From neuroprogression to neuroprotection: Implications for clinical care Med J Aust 193 2010 S36 S40
15. M. Berk, F. Kapczinski, A.C. Andreazza, O.M. Dean, F. Giorlando, and M. Maes Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors Neurosci Biobehav Rev 35 2011 804 817
16. F. Boufidou, C. Nikolaou, B. Alevizos, I.A. Liappas, and G.N. Christodoulou Cytokine production in bipolar affective disorder patients under lithium treatment J Affect Disord 82 2004 309 313
17. E.M. Knijff, R.W. Kupka, C. Ruwhof, M.N. Breunis, E.P. Prens, and W.A. Nolen Evidence that the immunopathogenic mechanism of lithium-induced psoriasis differs from that of regular psoriasis Bipolar Disord 7 2005 388 389
18. E.M. Knijff, M.N. Breunis, R.W. Kupka, H.J. de Wit, C. Ruwhof, and G.W. Akkerhuis An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: Restoration by lithium treatment Bipolar Disord 9 2007 743 753
19. S. Guloksuz, K. Altinbas, E. Aktas Cetin, G. Kenis, S. Bilgic Gazioglu, and G. Deniz Evidence for an association between tumor necrosis factor-alpha levels and lithium response J Affect Disord 143 2012 148 152
20. J.K. Soczynska, S.H. Kennedy, H.O. Woldeyohannes, S.S. Liauw, M. Alsuwaidan, and C.Y. Yim Mood disorders and obesity: Understanding inflammation as a pathophysiological nexus Neuromolecular Med 13 2011 93 116
21. I.G. Barbosa, N.P. Rocha, A.S. de Miranda, P.V. Magalhaes, R.B. Huguet, and L.P. de Souza Increased levels of adipokines in bipolar disorder J Psychiatr Res 46 2012 389 393
22. S.Y. Tsai, K.H. Chung, J.Y. Wu, C.J. Kuo, H.C. Lee, and S.H. Huang Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder J Affect Disord 136 2012 110 116
23. E. Brietzke, R.B. Mansur, J.K. Soczynska, F. Kapczinski, R.A. Bressan, and R.S. McIntyre Towards a multifactorial approach for prediction of bipolar disorder in at risk populations J Affect Disord 140 2012 82 91
24. M. Kauer-Sant'Anna, F. Kapczinski, A.C. Andreazza, D.J. Bond, R.W. Lam, and L.T. Young Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder Int J Neuropsychopharmacol 12 2009 447 458
25. T.T. Postolache, M. Lapidus, E.R. Sander, P. Langenberg, R.G. Hamilton, and J.J. Soriano Changes in allergy symptoms and depression scores are positively correlated in patients with recurrent mood disorders exposed to seasonal peaks in aeroallergens Sci World J 7 2007 1968 1977
26. R.D. Goodwin, F. Jacobi, and W. Thefeld Mental disorders and asthma in the community Arch Gen Psychiatry 60 2003 1125 1130
27. R.S. McIntyre, J.Z. Konarski, J.K. Soczynska, K. Wilkins, G. Panjwani, and B. Bouffard Medical comorbidity in bipolar disorder: Implications for functional outcomes and health service utilization Psychiatr Serv 57 2006 1140 1144
28. J.M. Jerrell, R.S. McIntyre, and A. Tripathi A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder J Clin Psychiatry 71 2010 1518 1525
29. M.N. Breunis, R.W. Kupka, W.A. Nolen, T. Suppes, K.D. Denicoff, and G.S. Leverich High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder Biol Psychiatry 53 2003 157 165
30. S.Y. Tsai, K.P. Chen, Y.Y. Yang, C.C. Chen, J.C. Lee, and V.K. Singh Activation of indices of cell-mediated immunity in bipolar mania Biol Psychiatry 45 1999 989 994
31. E. Brietzke, M. Kauer-Sant'Anna, A.L. Teixeira, and F. Kapczinski Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder Brain Behav Immun 23 2009 1079 1082
32. R.C. Drexhage, T.H. Hoogenboezem, M.A. Versnel, A. Berghout, W.A. Nolen, and H.A. Drexhage The activation of monocyte and T cell networks in patients with bipolar disorder Brain Behav Immun 25 2011 1206 1213
33. Y.J. Hung, C.H. Hsieh, Y.J. Chen, D. Pei, S.W. Kuo, and D.C. Shen Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder Clin Endocrinol (Oxf) 67 2007 784 789
34. I.G. Barbosa, R.B. Huguet, V.A. Mendonca, L.P. Sousa, F.S. Neves, and M.E. Bauer Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder Eur Arch Psychiatry Clin Neurosci 261 2011 139 143
35. I.G. Barbosa, N.P. Rocha, M.E. Bauer, A.S. de Miranda, R.B. Huguet, and H.J. Reis Chemokines in bipolar disorder: Trait or state? [published online ahead of print May 15] Eur Arch Psychiatry Clin Neurosci. 2012
36. A. Remlinger, P. Wojciak, J. Karczewski, A. Kostrzewa, K. Wiktorowicz, and J.K. Rybakowski The effect of mania on cytokine status in bipolar illness Eur Neuropsychopharmacol 19 2009 S462-S462
37. A. Remlinger-Molenda, P. Wojciak, A. Kostrzewa, J. Karczewski, K. Wiktorowicz, and J.K. Rybakowski Cytokine profiles in bipolar affective disorder during acute episodes and in remission Eur Neuropsychopharmacol 20 2010 S415 S416
38. S. Guloksuz, E.A. Cetin, T. Cetin, G. Deniz, E.T. Oral, and D.J. Nutt Cytokine levels in euthymic bipolar patients J Affect Disord 126 2010 458 462
39. Y.K. Kim, H.G. Jung, A.M. Myint, H. Kim, and S.H. Park Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder J Affect Disord 104 2007 91 95
40. S.M. O'Brien, P. Scully, L.V. Scott, and T.G. Dinan Cytokine profiles in bipolar affective disorder: focus on acutely ill patients J Affect Disord 90 2006 263 267
41. M.H. Rapaport Immune parameters in euthymic bipolar patients and normal volunteers J Affect Disord 32 1994 149 156
42. K.P. Su, S.J. Leu, Y.Y. Yang, W.W. Shen, Y.M. Chou, and S.Y. Tsai Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission J Affect Disord 71 2002 205 209
43. H.C. Liu, Y.Y. Yang, Y.M. Chou, K.P. Chen, W.W. Shen, and S.J. Leu Immunologic variables in acute mania of bipolar disorder J Neuroimmunol 150 2004 116 122
44. S. Hope, I. Dieset, I. Agartz, N.E. Steen, T. Ueland, and I. Melle Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia J Psychiatr Res 45 2011 1608 1616
45. F. Kapczinski, F. Dal-Pizzol, A.L. Teixeira, P.V. Magalhaes, M. Kauer-Sant'Anna, and F. Klamt Peripheral biomarkers and illness activity in bipolar disorder J Psychiatr Res 45 2011 156 161
46. M. Maes, E. Bosmans, J. Calabrese, R. Smith, and H.Y. Meltzer Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers J Psychiatr Res 29 1995 141 152
47. M.H. Rapaport, L. Guylai, and P. Whybrow Immune parameters in rapid cycling bipolar patients before and after lithium treatment J Psychiatr Res 33 1999 335 340
48. S.Y. Tsai, H.C. Lee, C.C. Chen, and C.H. Lee Plasma levels of soluble transferrin receptors and Clara cell protein (CC16) during bipolar mania and subsequent remission J Psychiatr Res 37 2003 229 235
49. V. Di Michele, F. Bolino, P. Pellegrini, T. Del Beato, D. Piancatelli, and A.M. Berghella The immunology of mood disorders: A comparison with healthy subjects and schizophrenics. Preliminary findings New Trend Exp Clin Psychiatry 11 1995 39 42
50. Y.K. Kim, A.M. Myint, B.H. Lee, C.S. Han, S.W. Lee, and B.E. Leonard T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients Psychiatry Res 129 2004 267 272
51. M. Kunz, K.M. Cereser, P.D. Goi, G.R. Fries, A.L. Teixeira, and B.S. Fernandes Serum levels of IL-6, IL-10 and TNF-alpha in patients with bipolar disorder and schizophrenia: Differences in pro- and anti-inflammatory balance Rev Bras Psiquiatr 33 2011 268 274
52. S. Gordon, and F.O. Martinez Alternative activation of macrophages: Mechanism and functions Immunity 32 2010 593 604
53. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 23 2002 549 555
54. P. Fietta, and G. Delsante The effector T helper cell triade Riv Biol 102 2009 61 74
55. S. Beissert, A. Schwarz, and T. Schwarz Regulatory T cells J Invest Dermatol 126 2006 15 24
56. M. Maes A review on the acute phase response in major depression Rev Neurosci 4 1993 407 416
57. M. Maes, J. Delange, R. Ranjan, H.Y. Meltzer, R. Desnyder, and W. Cooremans Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs Psychiatry Res 66 1997 1 11
58. F. Dickerson, C. Stallings, A. Origoni, J. Boronow, and R. Yolken Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder Prog Neuropsychopharmacol Biol Psychiatry 31 2007 952 955
59. A.M. Myint, Y.K. Kim, R. Verkerk, S.H. Park, S. Scharpe, and H.W. Steinbusch Tryptophan breakdown pathway in bipolar mania J Affect Disord 102 2007 65 72
60. M. Maes, A.H. Lin, R. Verkerk, L. Delmeire, A. Van Gastel, and M. Van der Planken Serotonergic and noradrenergic markers of post-traumatic stress disorder with and without major depression Neuropsychopharmacology 20 1999 188 197
61. K. Munkholm, M. Vinberg, and L. Vedel Kessing Cytokines in bipolar disorder: A systematic review and meta-analysis J Affect Disord 144 2013 16 27
62. D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, and D. Rennie Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
63. S.P. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med Res Methodol 5 2005 13
64. Higgins J (2011): Green S. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration. Available at: www.cochrane-handbook. org. Accessed February 3, 2013
65. C.L. Sistrom, and P.J. Mergo A simple method for obtaining original data from published graphs and plots AJR Am J Roentgenol 174 2000 1241 1244
66. F.N. Gumedze, and D. Jackson A random effects variance shift model for detecting and accommodating outliers in meta-analysis BMC Med Res Methodol 11 2011 19
67. P.V. Silva [Peripheral biomarkers in bipolar disorder: A population-based study in young adults] Arq Neuropsiquiatr 70 2012 79
68. M.P. Quinones, F. Jimenez, G. Perez-Algorta, K. Clark, S.S. Ahuja, and C.L. Bowden Central and peripheral immune activation in bipolar illness: Possible role of the chemokine CXCL5 in disease pathogenesis Biol Psychiatry 65 2009 169S
69. M.P. Quinones, G. Perez-Algorta, F. Jimenez, K. Clark, C.L. Bowden, and S.S. Ahuja Upregulation of type i immune responses in the brain of individuals with bipolar disorder: Uncoupling of central and peripheral responses Biol Psychiatry 65 2009 64S
70. M.P. Quinones, V. Torres, F.G. Nery, S. Ahmadi, C. Estrada, and R. Olvera Differential involvement of inflammatory markers in adult and pediatric bipolar disorder Biol Psychiatry 61 2007 11S
71. M.R. Quinones, S. Ahmadi, F.G. Nery, C. Estrada, R. Olvera, and J.R. Hatch Plasma TNF-RII as a new specific biomarker for the pathogenesis of bipolar disorder Biol Psychiatry 61 2007 6S
72. G.O. Doganavsargil-Baysal, H. Akbas, B. Cinemre, O. Metin, Z. Gokmen, and F. Davran Levels of TNF-alpha, soluble TNF receptors (sTNFR1, sTNFR2) and cognitive impairment in bipolar disorder Bipolar Disord 14 2012 71
73. M.P. Quinones, M. Nicoletti, R.L. Olvera, S.R. Pliszka, and J.C. Soares Tumor necrosis factor receptor-II (TNF-RII) a biomarker in bipolar disorder that links inflammation to cognitive dysfunction and neuroanatomical abnormalities Bipolar Disord 10 2008 85
74. A. Palomino, A. Aldama, M.O. Rojas-Corrales, J.A. Mico, E. Mosquera, and A. Gonzalez-Pinto Plasma levels of tumor necrosis factor-alpha (TNF alpha) in first-episode bipolar disorder and schizophrenia patients Eur Neuropsychopharmacol 15 2005 S565
75. L. Kirkby, and G. Modi The non-specific effect of lithium on interleukin 2 receptors (IL2Rs) and IL6Rs in lymphocytes of peripheral blood in bipolar mania type I J Neurol Neurosurg Psychiatry 74 2003 1167
76. M. Kauer-Sant'Anna Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs. late-state bipolar disorder Biol Psychiatry 69 2011 123S
77. M. Kunz, K.M.M. Cereser, G.R. Fries, A. Teixeira, B.S. Fernandes, and M. Kauer-Sant'Anna Serum levels of II6, II10 and TNF-alpha in patients with bipolar disorder in euthymia and with schizophrenia: Differences in pro and anti-inflammatory balance Biol Psychiatry 67 2010 132S
78. A.L. Teixeira, I.G. Barbosa, N.P. Rocha, A.S. Miranda, R.B. Huguet, and H.J. Reis Altered profile of chemokines in patients with bipolar disorder type 1 Biol Psychiatry 71 2012 279S
79. E. Brietzke, and A.L. Teixeira Similar immune profile in bipolar disorder and schizophrenia: Selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor Bipolar Disord 12 2010 453 454
80. S. Hope, I. Melle, P. Aukrust, N.E. Steen, A.B. Birkenaes, and S. Lorentzen Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor Bipolar Disord 11 2009 726 734
81. E.M. Knijff, M.N. Breunis, M.C. van Geest, R.W. Kupka, C. Ruwhof, and H.J. de Wit A relative resistance of T cells to dexamethasone in bipolar disorder Bipolar Disord 8 2006 740 750
82. I.G. Barbosa, R.B. Huguet, V.A. Mendonca, L.P. de Sousa, F.S. Neves, and M.E. Bauer Increased plasma levels of soluble TNF-alpha receptors in bipolar disorder patients Bipolar Disord 12 2010 6
83. E. Brietzke, L. Stertz, B.S. Fernandes, M. Kauer-Sant'Anna, M. Mascarenhas, and A.E. Vargas Comparison of cytokine levels in depressed, manic, and euthymic patients with bipolar disorder Bipolar Disord 12 2010 10 11
84. S. Guloksuz, E. Aktas, T. Cetin, G. Deniz, and T. Oral Cytokine levels in euthymic bipolar patients Bipolar Disord 12 2010 24
85. A. Palomino, A. Aldama, O. Rojas, J.A. Mico, F. Mosquera, and A. Gonzalez-Pinto Plasma levels of TNF alpha in first-episode bipolar disorder and schizophrenia patients Bipolar Disord 7 2005 84
86. Y.K. Kim, A.M. Myint, C.S. Han, H.W.M. Steinbusch, M. Maes, and B.E. Leonard Th1, Th2 and Th3 cytokine alterations in bipolar disorder: Effects of mood stabilizers Eur Neuropsychopharmacol 14 2004 S178
87. H.C. Lee, S.Y. Tsai, S.J. Lee, Y.Y. Yang, and K.P. Chen Effects of psychotropic agents on plasma levels of soluble interleukin-2 and interleukin-6 receptors in bipolar mania Eur Neuropsychopharmacol 10 2000 S227 S228
88. S.Y. Tsai, K.H. Chung, and S.H. Huang No state-dependent alternation of immunological parameters, insulin, and leptin during bipolar depression Eur Neuropsychopharmacol 20 2010 S419
89. A.L. Teixeira, I.G. Barbosa, R.B. Huguet, and M.E. Bauer Inflammatory parameters and neurotrophic factors in bipolar disorder: searching trait and state biomarkers Inflamm Res 60 2011 213 214
90. I.G. Barbosa, N.P. Rocha, R.B. Huguet, R.A. Ferreira, J.V. Salgado, and L.A. Carvalho Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers J Affect Disord 137 2012 151 155
91. K.P. Su, S.J.C. Leu, Y.Y. Yang, W.W. Shen, Y.M. Chou, and S.Y.M. Tsai Erratum to Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission [J Affect Disord 2002;7:205-209, PII: S016503270100369X] J Affect Disord 73 2003 299
92. I.G. Barbosa, N.R. Pessoa, R.B. Huguet, R.A. Ferreira, L.A. Carvalho, and C.M. Pariante Cognitive function and plasma levels of neurotrophic and inflammatory parameters in patients with bipolar disorder J Psychopharmacol 25 2011 A15
93. S. Hope, I. Melle, T. Ueland, S. Lorentzen, N.E. Steen, and A.Q. Berg Interleukin 1 receptor antagonist and tumor necrosis factor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder Schizophr Bull 37 2011 115 116
94. Y.K. Kim, I.B. Suh, H. Kim, C.S. Han, C.S. Lim, and S.H. Choi The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: Effects of psychotropic drugs Mol Psychiatry 7 2002 1107 1114
95. I. Dieset, S. Hope, T. Ueland, T. Bjella, I. Agartz, and I. Melle Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein Schizophr Res 140 2012 169 174
96. A. Remlinger-Molenda, P. Wojciak, M. Michalak, J. Karczewski, and J.K. Rybakowski Selected cytokine profiles during remission in bipolar patients Neuropsychobiology 66 2012 193 198
97. A. Remlinger-Molenda, P. Wójciak, M. Michalak, and J. Rybakowski Activity of selected cytokines in bipolar patients during manic and depressive episodes [in Polish] Psychiatr Pol 46 2012 599 611
98. S.C. Su, M.T. Sun, M.J. Wen, C.J. Lin, Y.C. Chen, and Y.J. Hung Brain-derived neurotrophic factor, adiponectin, and proinflammatory markers in various subtypes of depression in young men Int J Psychiatry Med 42 2011 211 226
99. T. Cetin, S. Guloksuz, E. Aktas Cetin, S. Bilgic Gazioglu, G. Deniz, and T.E. Oral Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms BMC Psychiatry 12 2012 158
100. do Prado CH, Rizzo LB, Wieck A, Lopes RP, Teixeira AL, Grassi-Oliveira R, et al. (2012): Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder [published online ahead of print September 14]. Psychoneuroendocrinology.
101. B.J. Miller, P. Buckley, W. Seabolt, A. Mellor, and B. Kirkpatrick Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects Biol Psychiatry 70 2011 663 671
102. J.D. Fontenot, J.P. Rasmussen, M.A. Gavin, and A.Y. Rudensky A function for interleukin 2 in Foxp3-expressing regulatory T cells Nat Immunol 6 2005 1142 1151
103. A. O'Garra, P.L. Vieira, P. Vieira, and A.E. Goldfeld IL-10-producing and naturally occurring CD4+ Tregs: Limiting collateral damage J Clin Invest 114 2004 1372 1378
104. S.A. Jones, S. Horiuchi, N. Topley, N. Yamamoto, and G.M. Fuller The soluble interleukin 6 receptor: mechanisms of production and implications in disease FASEB J 15 2001 43 58
105. S.A. Jones, and S. Rose-John The role of soluble receptors in cytokine biology: The agonistic properties of the sIL-6R/IL-6 complex Biochim Biophys Acta 1592 2002 251 263
106. P. Marz, T. Herget, E. Lang, U. Otten, and S. Rose-John Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation Eur J Neurosci 9 1997 2765 2773
107. P. Marz, K. Heese, B. Dimitriades-Schmutz, S. Rose-John, and U. Otten Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression Glia 26 1999 191 200
108. I.G. Barbosa, R.B. Huguet, F.S. Neves, H.J. Reis, M.E. Bauer, and Z. Janka Impaired nerve growth factor homeostasis in patients with bipolar disorder World J Biol Psychiatry 12 2011 228 232
109. U. Otten, P. Marz, K. Heese, C. Hock, D. Kunz, and S. Rose-John Cytokines and neurotrophins interact in normal and diseased states Ann N Y Acad Sci 917 2000 322 330
110. B.I. Goldstein, K.A. Collinger, F. Lotrich, A.L. Marsland, M.K. Gill, and D.A. Axelson Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders J Child Adolesc Psychopharmacol 21 2011 479 484
111. M. Raffa, S. Barhoumi, F. Atig, C. Fendri, A. Kerkeni, and A. Mechri Reduced antioxidant defense systems in schizophrenia and bipolar I disorder Prog Neuropsychopharmacol Biol Psychiatry 39 2012 371 375
112. A.V. Steckert, S.S. Valvassori, M. Moretti, F. Dal-Pizzol, and J. Quevedo Role of oxidative stress in the pathophysiology of bipolar disorder Neurochem Res 35 2010 1295 1301
113. S. Papiol, V. Molina, M. Desco, A. Rosa, S. Reig, and J. Sanz Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13) Genes Brain Behav 7 2008 796 801
114. S. Papiol, A. Rosa, B. Gutierrez, B. Martin, P. Salgado, and R. Catalan Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder J Med Genet 41 2004 219 223
115. R.C. Padmos, M.H. Hillegers, E.M. Knijff, R. Vonk, A. Bouvy, and F.J. Staal A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes Arch Gen Psychiatry 65 2008 395 407
116. S.J. Kim, H.J. Lee, H.G. Koo, J.W. Kim, J.Y. Song, and M.K. Kim Impact of IL-1 receptor antagonist gene polymorphism on schizophrenia and bipolar disorder Psychiatr Genet 14 2004 165 167
117. I.P. Oswald, R.T. Gazzinelli, A. Sher, and S.L. James IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity J Immunol 148 1992 3578 3582
118. R.C. Padmos, L. Bekris, E.M. Knijff, H. Tiemeier, R.W. Kupka, and D. Cohen A high prevalence of organ-specific autoimmunity in patients with bipolar disorder Biol Psychiatry 56 2004 476 482
119. M. Haack, D. Hinze-Selch, T. Fenzel, T. Kraus, M. Kuhn, and A. Schuld Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis J Psychiatr Res 33 1999 407 418
120. C.U. Chae, R.T. Lee, N. Rifai, and P.M. Ridker Blood pressure and inflammation in apparently healthy men Hypertension 38 2001 399 403
121. J.J. Diez, A. Hernanz, S. Medina, C. Bayon, and P. Iglesias Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function Clin Endocrinol (Oxf) 57 2002 515 521
122. A. Imhof, M. Froehlich, H. Brenner, H. Boeing, M.B. Pepys, and W. Koenig Effect of alcohol consumption on systemic markers of inflammation Lancet 357 2001 763 767
123. P.S. Tappia, K.L. Troughton, S.C. Langley-Evans, and R.F. Grimble Cigarette smoking influences cytokine production and antioxidant defences Clin Sci (Lond) 88 1995 485 489